Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -1.45% | 193.60 | 1.2% | $599.84m | |
| GILD | Gilead Sciences, Inc. | -0.87% | 66.98 | 0.9% | $498.93m | |
| CELG | Celgene Corporation | 1.54% | 67.78 | 1.2% | $483.99m | |
| BIIB | Biogen Inc. | -0.65% | 317.41 | 1.3% | $463.13m | |
| ILMN | Illumina, Inc. | 2.52% | 308.68 | 3.5% | $396.36m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.48% | 342.29 | 2.6% | $295.94m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.75% | 160.95 | 1.9% | $260.45m | |
| A | Agilent Technologies, Inc. | 1.13% | 68.28 | 1.5% | $218.37m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.66% | 118.76 | 2.0% | $203.88m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.38% | 116.73 | 15.4% | $145.45m | |
| LGND | Ligand Pharmaceuticals Incorporated | 2.34% | 152.35 | 23.1% | $140.62m | |
| EXAS | Exact Sciences Corporation | 2.89% | 66.60 | 25.3% | $134.28m | |
| TSRO | TESARO, Inc. | -3.48% | 41.00 | 14.4% | $133.90m | |
| NKTR | Nektar Therapeutics | -1.94% | 37.38 | 5.6% | $119.60m | |
| INCY | Incyte Corporation | 0.53% | 63.93 | 2.5% | $113.56m |
Company Profile
Pulmatrix, Inc. is a clinical stage biotechnology company, which engages in the discovery and development of novel inhaled therapeutic products. The company focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The company was founded by David Edwards, Mark Gabrielson, Alexander Klibanov, and Robert Langer on June 15, 2015 and is headquartered in Lexington, MA.